Miguel Manzur, MD
Vascular Surgery · Los Angeles, CANPI 1336560085
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (36.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Stryker at 30.6% of the total. 2025 is the largest year on record at $44,464, more than ten times the $3,025 reported in 2019. Among vascular surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 374 payments — averaging $234.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$27K
- Medtronic$13K
- Shockwave Medical, Inc$11K
- Cvrx, Inc.$8K
- Inari Medical, Inc.$5K
- W. L. Gore & Associates, Inc.$4K
- plus $20K from 29 others
Across 7 payments — averaging $3148.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cvrx, Inc.$22K
What the payments were for
- Consulting fees$32,17337%
- Speaking & faculty fees$11,05013%
- Grants$3030%
- Travel & lodging$22,86826%
- Food & beverage$20,58723%
- Education$7171%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 20 | $26,854 |
| Medtronic | 85 | $12,832 |
| Shockwave Medical, Inc | 26 | $11,228 |
| Cvrx, Inc. | 18 | $7,741 |
| Inari Medical, Inc. | 16 | $5,305 |
| W. L. Gore & Associates, Inc. | 51 | $4,159 |
| Penumbra, Inc. | 13 | $3,862 |
| Cook Medical LLC | 39 | $3,650 |
| Angiodynamics, Inc. | 17 | $3,483 |
| Boston Scientific | 17 | $2,974 |
| Surmodics, Inc. | 8 | $1,200 |
| Globus Medical | 6 | $941 |
| Bolton Medical Inc | 6 | $614 |
| Abbott | 7 | $535 |
| Koya Medical, Inc. | 2 | $444 |
| Silk Road Medical, Inc. | 5 | $440 |
| Endologix LLC | 4 | $302 |
| Baxter Healthcare | 3 | $217 |
| Shape Memory Medical Inc. | 1 | $150 |
| Getinge USA Sales, LLC | 12 | $149 |
| Merit Medical Systems Inc | 2 | $141 |
| KARL Storz Endoscopy-america | 1 | $93 |
| Humacyte Global, Inc. | 2 | $70 |
| Amgen | 1 | $56 |
| KCI USA, Inc. | 2 | $43 |
| Cagent Vascular Inc | 1 | $27 |
| Philips North America LLC | 1 | $26 |
| Imperative Care, Inc | 1 | $26 |
| Urgo Medical North America, LLC | 1 | $25 |
| Convatec Inc. | 1 | $23 |
| Cordis US CORP. | 1 | $22 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $21 |
| Bard Peripheral Vascular, Inc. | 1 | $19 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
| Lemaitre Vascular, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CT THROMBECTOMY SYSTEM KIT$26,230
- FLOWTRIEVER CATHETER, S$26,230
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$10,965
- IN.PACT Admiral$8,664
- Barostim Neo System$7,425
- LIMFLOW SYSTEM$5,031
- Indigo System$1,979
- AngioVac$1,781
- RUBY Coil$1,693
- GENERAL - THERAPIES$1,250
- Dayspring$1,211
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$1,158
- Auryon Laser System 100-120 Vac$1,154
- Sublime 014 Rx PTA Balloon Dilatation Catheter$1,084
- Sublime Microcatheter, 018, 200cm, Straight$1,084
- ALIF$817
- JETSTREAM SC$691
- EXCLUDER AAA Endoprosthesis$594
- Cook$590
- GORE EXCLUDER AAA Endoprosthesis$495
How this compares
$87,698 in reported general payments places this provider in the 95th percentile of 519 vascular surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $7,509 |
| Gentamicin Sulfate | 19 | $852 |
| ClopidogrelClopidogrel Bisulfate | 12 | $174 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Los Angeles
- Sukgu HanLos Angeles$477K
- Johnathon RolloLos Angeles$337K
- Gregory MageeLos Angeles$152K
- Rajeev RaoLos Angeles$107K
- Juan JimenezLos Angeles$91K
- Bernardo Curi MendesLos Angeles$76K
- William Quinones-BaldrichLos Angeles$53K
- Sharon KiangLos Angeles$46K
- Fred WeaverLos Angeles$42K
- Donald BarilLos Angeles$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.